close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Merakris Therapeutics

News headline image
FDA Grants Fast Track Designation to Merakris’ MTX-001, Opening Potential Accelerated Path to Market for Venous Leg Ulcer Therapy
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Merakris Therapeutics and iFyber Collaboration Receives Top SAWC Research Award for MTX-001 Wound Healing Study in Human Skin Model
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Merakris Therapeutics Provides FDA Update and Reports Interim Findings for MTX-001 in Venous Leg Ulcers
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Merakris Therapeutics Chief Scientific Officer Dr. Roger Ilagan to Present at Innovations in Wound Healing Symposium
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Merakris Therapeutics Announces Completion of Type C Meeting with FDA – Alignment on MTX-001 Biologic Drug Development Pathway
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Merakris Therapeutics Secures FDA Agreement for Type C Meeting to Advance MTX-001 Development Pathway
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Merakris Therapeutics Enrolls 30th Subject in Expanded Access Program of MTX-001; Highlights Clinical Progress at SAWC Fall 2025
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Merakris Therapeutics Receives USPTO Notice of Allowance for Foundational Patent Supporting MTX-001 Biologic Drug Platform
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Merakris Therapeutics Spotlights Investigational New Drug, MTX-001, with Innovation Showcase Win at 2025 Advanced Wound Care Summit
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Merakris Therapeutics Selected as Finalist for 2025 Advanced Would Care Summit Innovation Showcase
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Merakris Therapeutics Appoints Roger Ilagan to Chief Scientific Officer
From Merakris Therapeutics
Via GlobeNewswire
News headline image
International Wound Journal Publishes Positive Phase 2 Interim Data on Cell-free Amniotic Fluid Injectable Biologic for the Treatment of Venous Leg Ulcers
From Merakris Therapeutics
Via GlobeNewswire
News headline image
2025 CAMPS Summit Selects Merakris Therapeutics’ Scientist with Inaugural “Best Comparative Trial” Award
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Merakris Therapeutics Announces Open Enrollment for Phase II Clinical Trial of Subcutaneous Injection Drug for the Treatment of Venous Leg Ulcer
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Merakris Therapeutics Introduces Dermacyte® AC Matrix: A Lyophilized Amnion Chorion Allograft
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Merakris Therapeutics Announces FDA Clearance for Part 2 of its Phase II Multicenter Investigational New Drug Study of Dermacyte® Liquid
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Jonathan Berlent Joins Merakris as SVP, Head of Strategy and Operations
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Favorable Results From Dermacyte® Matrix Research Study Published in March Issue of Journal of Wound Care
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Merakris Therapeutics to Release Final Part 1 Data From Phase 2 Multicenter Investigational Drug Study for Dermacyte® Liquid
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Merakris To Share Data from Fully Enrolled First Part of Two-Part Dermacyte® Liquid Clinical Trial
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Merakris Announces Nationwide At-Your-Door Autologous Serum Tears Program
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Wound Healing Technology Company Merakris Adds Two Executives to Leadership Team
From Merakris Therapeutics
Via GlobeNewswire
News headline image
Merakris Announces Review in Biomedicines Medical Journal Highlights Therapeutic Potential of Cell-Free Amniotic Fluid
From Merakris Therapeutics
Via GlobeNewswire
News headline image
First Patient Enrolled in Merakris-Sponsored VA Clinical Trial
From Merakris Therapeutics
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today